Related Experiment Video
Updated: Feb 18, 2026

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
Published on: May 27, 2022
Fungaemia Caused by the Rare Yeast Starmerella sorbosivorans: A Case Report with Identification via Molecular
Shunkichi Ikegaki1, Yuka Nagatsuka2,3, Sayaka Ban4
1Division of Infectious Disease Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan. ikegaki@gmail.com.
Abstract:
Invasive yeast infections are associated with high mortality rates, particularly in immunocompromised patients. While most cases of fungaemia are caused by Candida species, rare yeast infections occasionally occur. Here, we present the first documented case of a Starmerella sorbosivorans (= Candida sorbosivorans, homotypic synonym) bloodstream infection in a 39 year-old man with chronic intestinal pseudo-obstruction requiring parenteral nutrition via a tunnelled central venous catheter. The patient presented with fever and was diagnosed with catheter-related bloodstream infection. Initial biochemical identification suggested S. magnoliae, but MALDI-TOF mass spectrometry (MS) failed to provide a definitive identification. Molecular phylogenetic analysis using multiple loci (18S rDNA, internal transcribed spacer [ITS] region, 26S rDNA-D1/D2, TEF1α, and RPB2), combined with proteomic analysis using MALDI-TOF MS, confirmed the isolate as S. sorbosivorans, despite a low ITS sequence similarity (91.3%) to the type strain. The patient was successfully treated with sequential administration of micafungin and liposomal amphotericin B, along with removal of the catheter. Antifungal susceptibility testing revealed low minimum inhibitory concentrations (MICs) for micafungin, amphotericin B, and voriconazole, but high MICs for fluconazole. Our findings emphasise the importance of multilocus sequence analysis for accurate species identification, especially in rare yeast infections caused by uncommon species such as S. sorbosivorans, for which conventional methods may be insufficient. However, to improve the applicability of MALDI-TOF MS in clinical settings, the reference library should be expanded to include rare and emerging yeast species.
Insights
This study reports the first case of Starmerella sorbosivorans bloodstream infection in a patient requiring parenteral nutrition. Multilocus sequence analysis confirmed the rare yeast identification, leading to successful antifungal treatment.
Area of Science:
- Medical Mycology
- Clinical Microbiology
- Infectious Diseases
Background:
- Invasive yeast infections, primarily Candida bloodstream infections, carry high mortality, especially in immunocompromised individuals.
- Rare yeast species can cause fungaemia, posing diagnostic challenges with conventional methods.
- Starmerella sorbosivorans (formerly Candida sorbosivorans) is an uncommon yeast species not frequently implicated in human infections.
Purpose of the Study:
- To document the first case of Starmerella sorbosivorans bloodstream infection.
- To highlight the diagnostic challenges and the importance of advanced molecular techniques for identifying rare yeast pathogens.
- To report successful treatment outcomes and antifungal susceptibility profiles for this rare infection.
Main Methods:
- Case report of a patient with chronic intestinal pseudo-obstruction and a central venous catheter.
- Initial identification using standard biochemical methods and MALDI-TOF mass spectrometry (MS).
- Definitive identification through molecular phylogenetic analysis of multiple gene loci (18S rDNA, ITS, 26S rDNA-D1/D2, TEF1α, RPB2) and MALDI-TOF MS.
- Antifungal susceptibility testing (AST) to determine minimum inhibitory concentrations (MICs).
Main Results:
- A 39-year-old male patient with a tunnelled central venous catheter developed fever, diagnosed as catheter-related bloodstream infection.
- Biochemical tests suggested S. magnoliae, but MALDI-TOF MS was inconclusive.
- Multilocus sequence analysis and MALDI-TOF MS confirmed the isolate as Starmerella sorbosivorans, with 91.3% ITS sequence similarity to the type strain.
- The patient responded well to treatment with micafungin and liposomal amphotericin B, along with catheter removal.
- Antifungal susceptibility revealed low MICs for micafungin, amphotericin B, and voriconazole, but high MICs for fluconazole.
Conclusions:
- Accurate identification of rare yeast species like S. sorbosivorans necessitates advanced molecular methods beyond conventional techniques and standard MALDI-TOF MS libraries.
- Multilocus sequence analysis is crucial for definitive species identification in challenging clinical cases.
- Expanding MALDI-TOF MS reference databases with rare and emerging yeast species is vital for improving clinical diagnostic capabilities.
- Successful treatment outcomes can be achieved with appropriate antifungal agents based on susceptibility testing.
More Related Videos
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Fungal Phylum Ascomycota
Fungal Phylum Basidiomycota
Overview of Fungi

